Rollins (NYSE:ROL) received mixed analyst ratings in the latest quarter, with 3 bullish and 1 indifferent rating. The average 12-month price target is $45.25, slightly up from the previous $45.00. Analysts from Goldman Sachs, Morgan Stanley, UBS, and Stifel provided recent evaluations, with price targets ranging from $40.00 to $50.00. Rollins, a global pest-control service provider, showed a revenue growth of 15.17% and a net margin of 15.2%, with an ROE of 10.45% and an ROA of 4.88%. The company maintains a low debt-to-equity ratio of 0.82.